Back to Woodline Partners LP Woodline Partners LP

EWEW
Showing 8 of 22 quarters

Position history for Woodline Partners LPWoodline Partners LP's holdings in EDWARDS LIFESCIENCES CORP

Yes. Woodline Partners holds 1,560,062 shares of EW (Edwards Lifesciences), worth $141.1M, as of its Q2 2026 13F filing. It reduced the position by 208,114 shares (-11.8%) from Q1 2026. Woodline Partners has held EW since Q4 2023, across 11 quarterly 13F filings. EW is 0.4% of Woodline Partners' reported 13F portfolio.

Current Value

$141.1M

Current Shares

1.6M

Total Value Change

+$117.8M

Total Shares Change

+1.2M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
1.6M
-11.8%
$141.1M0.4%$90.46
0
2026-Q1
Increased
1.8M
+65.2%
$141.6M0.5%$80.08
62
2025-Q4
Increased
1.1M
+91.3%
$91.3M0.4%$85.25
56
2025-Q3
Decreased
559,536
-45.1%
$43.5M0.2%$77.77
0
2025-Q2
Increased
1M
+23.6%
$79.8M0.4%$78.21
43
2025-Q1
Increased
825,358
+7805.0%
$59.8M0.4%$72.48
57
2024-Q4
Decreased
10,441
-97.0%
$772,9470.0%$74.03
0
2024-Q3
Increased
353,237
+32.8%
$23.3M0.2%$65.99
44

Other major holders of EW: BNP PARIBAS FINANCIAL MARKETS, VANGUARD GROUP INC, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used